Regulation of synaptic MAPK/ERK phosphorylation in the rat striatum and medial prefrontal cortex by dopamine and muscarinic acetylcholine receptors

Journal of Neuroscience Research

Volumn 93, Issue 10, 2015, Pages 1592-1599

  Xue, Bing ^a   Mao, Li Min ^a   Jin, Dao Zhong ^a   Wang, John Q ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; C Jun N terminal kinase; D1 dopamine receptor; Extracellular signal regulated kinase; M4 receptor; RRID:AB_10693936; RRID:AB_10695746; RRID:AB_2140557; RRID:AB_331646; RRID:AB_476693; RRID:nif 0000 30467; Stress activated protein kinase

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC RECEPTOR; QUINPIROLE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; IMMUNOBLOTTING; MALE; MEDIAL PREFRONTAL CORTEX; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PREFRONTAL CORTEX; SYNAPSE; WISTAR RAT;

ANIMALS; CHOLINERGIC AGENTS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MAP KINASE KINASE 2; PHOSPHORYLATION; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SYNAPSES;

EID: 84939466262     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23622     Document Type: Article

References (56)

1. Adams JP, Anderson AE, Varga AW, Dineley KT, Cook RG, Pfaffinger PJ, Sweatt JD. 2000. The A-type potassium channel Kv4.2 is a substrate for the mitogen-activated protein kinase ERK. J Neurochem 75:2277-2287.
2. 5 dopamine receptors in primate brain. J Neurosci 15:7821-7836.
3. Bernard V, Dumartin B, Lamy E, Bloch B. 1993. Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat. Eur J Neurosci 5:1218-1225.
4. Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Herve D, Valjent E, Girault JA. 2008. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28:5671-5685.
5. Bloem B, Schoppink L, Rotaru DC, Faiz A, Hendriks P, Mansvelder HD, van de Berg WD, Wouterlood FG. 2014. Topographic mapping between basal forebrain cholinergic neurons and the medial prefrontal cortex in mice. J Neurosci 34:16234-16246.
6. Boggio EM, Putignano E, Sassoe-Pognetto M, Pizzorusso T, Glustetto M. 2007. Visual stimulation activates ERK in synaptic and somatic compartments of rat cortical neurons with parallel kinetics. PLoS One 2:e604.
7. Bolam JP, Wainer BH, Smith AD. 1984. Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation, and electron microscopy. Neuroscience 12:711-718.
8. Brady AE, Jones CK, Bridges TM, Kennedy JP, Thompson AD, Heiman JU, Breininger ML, Gentry PR, Yin H, Jadhav SB, Shirey JK, Conn PJ, Lindsley CW. 2008. Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats. J Pharmacol Exp Ther 327:941-953.
9. 4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. Neuropsychopharmacology 39:1578-1593.
10. Casar B, Arozarena I, Sanz-Moreno V, Pinto A, Agudo-Ibanez L, Marais R, Lewis RE, Berciano MT, Crespo P. 2009. MTRas subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins. Mol Cell Biol 29:1338-1353.
11. Choe ES, Wang JQ. 2002. CaMKII regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons. Neuroreport 13:1013-1016.
12. Choe ES, Chung KT, Mao L, Wang JQ. 2002. Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27:565-575.
13. Chou H, Ogawa N, Asanuma M, Hirata H, Mori A. 1992. Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain. J Neural Transm 90:171-181.
14. de Almeida J, Palacios JM, Mengod G. 2008. Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment. Prog Brain Res 172:101-115.
15. Debata PR, Ranasinghe B, Berliner A, Curcio GM, Tantry SJ, Ponimaskin E, Banerjee P. 2010. Erk1/2-dependent phosphorylation of PKCalpha at threonine 638 in hippocampal 5-HT(1A) receptor-mediated signaling. Biochem Biophys Res Commun 397:401-406.
16. Di Chiara G, Morelli M, Consolo S. 1994. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17:228-233.
17. Fumagalli F, Caffino L, Racagni G, Riva MA. 2009. Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex. Eur Neuropsychopharmacol 19:402-408.
18. Gangarossa G, Valjent E. 2012. Regulation of the ERK pathway in the dentate gyrus by in vivo dopamine D1 receptor stimulation requires glutamatergic transmission. Neuropharmacology 63:1107-1117.
19. Gangarossa G, Di Benedetto M, O'Sullivan GJ, Dunleavy M, Alcacer C, Bonito-Oliva A, Henshall DC, Waddington JL, Valjent E, Fisone G. 2011. Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif/268 and Arc/Arg3.1 expression in mouse dentate gyrus. PLoS One 6:e19415.
20. Gangarossa G, Perroy J, Valjent E. 2013. Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum. Brain Struct Funct 218:405-419.
21. Guo ML, Xue B, Jin DZ, Mao LM, Wang JQ. 2012. Interactions and phosphorylation of postsynaptic density 93 (PSD-93) by extracellular signal-regulated kinase (ERK). Brain Res 1465:18-25.
22. Heidbreder CA, Groenewegen HJ. 2003. The medial prefrontal cortex in the rat: evidence for a dorsoventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 27:555-579.
23. Henny P, Jones B. 2008. Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic, and glutamatergic inputs to pyramidal cells or interneurons. Eur J Neurosci 27:654-670.
24. Ince E, Ciliax BJ, Levey AI. 1997. Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons. Synapse 27:357-366.
25. Jenab S, Festa ED, Nazarian A, Wu HB, Sun WL, Hazim R, Russo SJ, Quinones-Jenab V. 2005. Cocaine induction of ERK proteins in dorsal striatum of Fischer rats. Brain Res Mol Brain Res 142:134-138.
26. Jovanovic JN, Benfenati F, Siow YL, Sihra TS, Sanghera JS, Pelech SL, Greengard P, Czernik AJ. 1996. Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc Natl Acad Sci U S A 93:3679-3683.
27. Kosako H, Yamaguchi N, Aranami C, Ushiyama M, Kose S, Imamoto N, Taniguchi H, Nishida E, Hattori S. 2009. Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport. Nat Struct Mol Biol 16:1026-1035.
28. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. 1991. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11:3218-3226.
29. Mao LM, Reusch JM, Fibuch EE, Liu Z, Wang JQ. 2013. Amphetamine increases phosphorylation of MAPK/ERK at synaptic sites in the rat striatum and medial prefrontal cortex. Brain Res 1494:101-108.
30. 2 mediated response. Neuroscience 53:673-678.
31. Nozaki K, Nishimura M, Hashimoto N. 2001. Mitogen-activated protein kinases and cerebral ischemia. Mol Neurobiol 23:1-19.
32. Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, Nestler EJ. 1995. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15:1285-1297.
33. Park JM, Hu JH, Milshteyn A, Zhang PW, Moore CG, Park S, Datko MC, Domingo RD, Reyes CM, Wang XJ, Etzkorn FA, Xiao B, Szumlinski KK, Kern D, Linden DJ, Worley PF. 2013. A prolyl-isomerase mediates dopamine-dependent plasticity and cocaine motor sensitization. Cell 154:637-650.
34. Pearson G, Robinson F, Gibson BT, Xu BE, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation of physiological functions. Endocrine Rev 22:153-183.
35. Sabio G, Reuver S, Feijoo C, Hasegawa M, Thomas GM, Centeno F, Kuhlendahl F, Leal-Ortiz S, Goedert M, Garner C, Cuenda A. 2004. Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38gamma and ERK1/ERK2. Biochem J 380:19-30.
36. Santiago MP, Potter LT. 2001. Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons. Brain Res 894:12-20.
37. Schrader LA, Birnbaum SG, Nadin BM, Ren Y, Bui D, Anderson AE, Sweatt JD. 2006. ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit. Am J Physiol Cell Physiol 290:C852-C861.
38. Shi X, McGinty JF. 2011. D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats. Psychopharmacology 214:653-663.
39. Steketee JD. 2003. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Rev 41:203-228.
40. Sun WL, Zhou L, Hazim R, Quinones-Jenab V, Jenab S. 2007. Effects of acute cocaine on ERK and DARPP-32 phosphorylation pathways in the caudate-putamen of Fischer rats. Brain Res 1178:12-19.
41. Sweatt JD. 2004. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14:311-317.
42. Thomas GM, Huganir RL. 2004. MAPK cascade signaling and synaptic plasticity. Nat Rev Neurosci 5:173-183.
43. Treisman R. 1996. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8:205-215.
44. Valjent E, Corvol JC, Pages C, Besson MJ, Maldonado R, Caboche J. 2000. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 20:8701-8709.
45. Valjent E, Pages C, Herve D, Girault JA, Caboche J. 2004. Addictive and nonaddictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19:1826-1836.
46. Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JG, Stipanovich A, Caboche J, Lombroso PJ, Nairn AC, Greengard P, Herve D, Girault JA. 2005. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A 102:491-496.
47. Valjent E, Corvol JC, Trzaskos JM, Girault JA, Herve D. 2006. Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neurosci. 7:20.
48. Van den Oever MC, Spijker S, Smit AB, De Vries TJ. 2010. Prefrontal cortex plasticity mechanisms in drug seeking and relapse. Neurosci Biobehav Rev 35:276-284.
49. Volmat V, Pouyssegur J. 2001. Spatiotemporal regulation of the p42/p44 MAPK pathway. Biol Cell 93:71-79.
50. Volpicelli LA, Levey AI. 2004. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 145:59-66.
51. Wang JQ, McGinty JF. 1996. Scopolamine augments c-fos and zif/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-81297 in the intact rat striatum. Neuroscience 72:601-616.
52. Wang JQ, McGinty JF. 1997. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res 748:62-70.
53. Wang JQ, Fibuch EE, Mao LM. 2007. Regulation of mitogen-activated protein kinases by glutamate receptors. J Neurochem 100:1-11.
54. Yang L, Mao L, Chen H, Catavsan M, Kozinn J, Arora A, Liu X, Wang JQ. 2006. A signaling mechanism from Gαq-protein-coupled glutamate receptors to gene expression: role of the c-Jun N-terminal kinase pathway. J Neurosci 26:971-980.
55. Zhang GC, Mao LM, Liu XY, Parelkar NK, Arora A, Yang L, Haines M, Fibuch EE, Wang JQ. 2007. In vivo regulation of Homer1a expression in the striatum by cocaine. Mol Pharmacol 71:1148-1158.
56. Zhang L, Lou D, Jiao H, Zhang D, Wang X, Xia Y, Zhang J, Xu M. 2004. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 24:3344-3354.